A novel double fusion of EML4-ALK and PLEKHA7-ALK contribute to rapid progression of lung adenocarcinoma: a case report and literature review by Zhongzhao Wang, Yang Luo, Heng Gong, Yang Chen, Hao Tang

Subjects: “…ALK fusion…”
Get full text

The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment—Literature Review by Anita Gorzelak-Magiera, Małgorzata Domagała-Haduch, Jacek Kabut, Iwona Gisterek-Grocholska

Subjects: “…ALK-TKI…”
Get full text

Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer by Dafeng Guo, Yu Yu, Binyu Long, Ping Deng, Dongzhi Ran, Lei Han, Jiecheng Zheng, Zongjie Gan

Subjects: “…ALK…”
Get full text

Global research trends on ALK-TKIs in non-small cell lung cancer: a bibliometric analysis by Yafeng Liu, Zhaojin Han, Yujia Li, Pengfei Zhang, Qiushi Wang

Subjects: Get full text

A 4-year-old Boy with a Red Nodule on His Hand: A Quiz by Riku Ishii, Noriyuki Otsuka, Takashi Anan, Yuhei Yamamoto, Taku Maeda

Subjects: Get full text

The GntR/VanR transcription regulator AlkR represses AlkB2 monooxygenase expression and regulates n‐alkane degradation in Pseudomonas aeruginosa SJTD‐1 by Wanli Peng, Xiuli Wang, Qinchen Liu, Zhihong Xiao, Fulin Li, Nannan Ji, Zhuo Chen, Jiaying He, Junhao Wang, Zixin Deng, Shuangjun Lin, Rubing Liang

Subjects: “…AlkB2 monooxygenase…”
Get full text

Mechanisms of Resistance to ALK Inhibitors and Corresponding Treatment Strategies in Lung Cancer by Xie J, Gao Y, Xu W, Zhu J

Subjects: “…eml4-alk…”
Get full text

Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inh... by Lara Chayab, Natasha B. Leighl, Mina Tadrous, Christine M. Warren, William W. L. Wong

Subjects: Get full text

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer by Peng Song, Xiaotong Zhang, Dongliang Yang, Hanping Wang, Xiaoyan Si, Li Zhang

Subjects: “…ALK…”
Get full text

Molecular genetic features of neuroblastoma in adolescent by N. A. Andreeva, T. V. Shamanskaya, D. Yu. Kachanov, R. Kh. Abasov, N. V. Gegeliya, A. E. Druy

Subjects: Get full text

ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India by Ajita Verma, Zachariah Chowdhury, Anil Singh, Abhinav Kant, Anil Yadav, Shashikant C.U. Patne

Subjects: Get full text

Coexistence of a novel SV2B-ALK, EML4-ALK double-fusion in a lung poorly differentiated adenocarcinoma patient and response to alectinib: a case report and literature review by Huang Chen, Menglan Zhang, Liyan Bai, Yun Niu, Xiaowei Wang, Ruiying Jiang, Ye Wang, Qianqian Feng, Bei Wang, Tingli Dai, Mingming Yuan, Rongrong Chen, Yujuan Qi, Dingrong Zhong

Subjects: Get full text

An Isolated Cutaneous Relapse in a Known Case of Systemic ALK-Positive Anaplastic Large Cell Lymphoma: A Rare Case Report with Review of Literature by Monisha Shetty, Banavasi Shanmukha Girisha, Sona C. Gowda, Vijith Shetty

Subjects: Get full text

A new ALK inhibitor overcomes resistance to first‐ and second‐generation inhibitors in NSCLC by Yue Lu, Zhenzhen Fan, Su‐Jie Zhu, Xiaoxing Huang, Zhongji Zhuang, Yunzhan Li, Zhou Deng, Lei Gao, Xuehui Hong, Ting Zhang, Li Li, Xihuan Sun, Wei Huang, Jingfang Zhang, Yan Liu, Baoding Zhang, Jie Jiang, Fu Gui, Zheng Wang, Qiyuan Li, Siyang Song, Xin Huang, Qiao Wu, Lanfen Chen, Dawang Zhou, Jianming Zhang, Cai‐Hong Yun, Liang Chen, Xianming Deng

Subjects: Get full text

Промежуточные результаты проспективного рандомизированного сравнительного исследования эффективности программ NHL BFM-90 и СНОЕР у первичных пациентов с ALK-позитивной анапластичес... by Лилия Гамилевна Горенкова, С. К. Кравченко, Е. Е. Клебанова, А. М. Ковригина, К. А. Сычевская, Э. Г. Гемджян, Е. С. Нестерова, Я. К. Мангасарова, А. В. Мисюрин, Ю. В. Сидорова, Т. Н. Обухова

Subjects: Get full text

Comprehensive study of anaplastic large cell lymphoma: clinicopathological features from Indonesia by Agnes Stephanie Harahap, Ivana Santoso, Stefanny Charles, Nadia Ayu Mulansari, Maria Francisca Ham

Subjects: Get full text

Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma by Seema Chugh, Jean C. Tien, Jennifer Hon, Carson Kenum, Rahul Mannan, Yunhui Cheng, Chi Chiang Li, Zainab I. Taher, Andrew D. Delekta, Pushpinder Singh Bawa, Ingrid J. Apel, Stephanie J. Miner, Xuhong Cao, Rohit Mehra, Saravana M. Dhanasekaran, Yuanyuan Qiao, Rajen Mody, Arul M. Chinnaiyan

Subjects: Get full text

Efficacy and safety analysis of lorlatinib for ALK-positive advanced NSCLC: a multicentre real-world study in China by Zhujun Chen, Chunlan Tang, Xiangyu Ma, Panwen Tian, Liang Gong

Subjects: “…ALK+…”
Get full text

Renal Inflammatory Myofibroblastic Tumor in an Infant: Case Report with Review of Literature by Vinayak Dave, Aekta Shah, Badira Parambil, Poonam Panjwani, Sajid Qureshi, Mukta Ramadwar

Subjects: Get full text

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung by Naoko Imanishi, Kazue Yoneda, Akihiro Taira, Yoshinobu Ichiki, Naoko Sato, Masanori Hisaoka, Fumihiro Tanaka

Subjects: “…ALK…”
Get full text